Atraumatic oral spray immunization with replication-deficient viral vector vaccines

Area of Science:

• Immunology
• Vaccinology
• Global Health

Background:

• Needle-free vaccine delivery is a grand challenge in global health.
• Current vaccine methods face challenges with acceptance, especially in children and developing nations.
• Mucosa-associated lymphatic tissue (MALT) is a potential target for atraumatic immunization.

Purpose of the Study:

• To investigate the potential of atraumatic immunization by targeting the mucosa-associated lymphatic tissue (MALT).
• To evaluate the efficacy of replication-deficient viral vector vaccines delivered via oral spray to the tonsils.
• To assess the induction of immune responses and protection against simian immunodeficiency virus (SIV) challenge.

Main Methods:

• Replication-deficient viral vector vaccines encoding simian immunodeficiency virus (SIV) antigens were administered via oral spray directly onto the tonsils of rhesus macaques.
• Immune responses, including cellular and humoral immunity, were measured after immunization.
• Animals were subsequently challenged with SIV to assess vaccine efficacy and protection.

Main Results:

• Tonsillar immunization with viral vector vaccines successfully induced both cellular and humoral immune responses.
• Following a stringent SIV challenge, viral RNA levels were reduced in immunized macaques.
• The level of protection achieved was comparable to that observed with traditional systemic immunization.

Conclusions:

• Atraumatic oral spray immunization with replication-deficient vectors can effectively bypass the epithelial barrier.
• Vaccine antigens can be delivered to the mucosa-associated lymphatic tissue (MALT), inducing protective immunity.
• This novel approach offers a promising alternative to needle-based vaccines, addressing acceptability issues for pediatric and global health initiatives.